Quote:

---

summits' ivonescimab approved for use in china - speculation that the chinese market is far larger than the US, but have to assume a significant retail price difference per dose - because mandatory stateside gouging

---

That the Chinese market is far larger is speculation. Drugs are much cheaper outside of the U.S. including China. But a large proportion of the Chinese population relies on herbal medications because of poverty. The CCP says they've eradicated poverty but it's a lie. The CCP arbitrarily declared that the poverty line is $2.30 a day. I guess you could afford aspirin if you skipped a few meals.